0001095449-20-000050.txt : 20200811
0001095449-20-000050.hdr.sgml : 20200811
20200810180705
ACCESSION NUMBER: 0001095449-20-000050
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200811
DATE AS OF CHANGE: 20200810
EFFECTIVENESS DATE: 20200811
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tamarack Advisers, LP
CENTRAL INDEX KEY: 0001661462
IRS NUMBER: 474492240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17119
FILM NUMBER: 201090607
BUSINESS ADDRESS:
STREET 1: 5050 AVENIDA ENCINAS
STREET 2: SUITE 360
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (760) 429-7254
MAIL ADDRESS:
STREET 1: 5050 AVENIDA ENCINAS
STREET 2: SUITE 360
CITY: CARLSBAD
STATE: CA
ZIP: 92008
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001661462
XXXXXXXX
06-30-2020
06-30-2020
Tamarack Advisers, LP
5050 AVENIDA ENCINAS
SUITE 360
CARLSBAD
CA
92008
13F HOLDINGS REPORT
028-17119
N
Andrew H. Fesler
Chief Compliance Officer
(760) 429-7254
Andrew H. Fesler
Carlsbad
CA
07-09-2020
0
33
359175
false
INFORMATION TABLE
2
table.2020-06.xml
13F HOLDINGS REPORT FOR JUNE 30, 2020
ABBOTT LABORATORIESEquity002824100685775000SHSOLE7500000
AMYRIS INCEquity03236M20056931333333SHSOLE133333300
ATRICURE INCEquity04963C20910114225000SHSOLE22500000
BIO-RAD LABORATORIES-AEquity0905722071354530000SHSOLE3000000
QUEST DIAGNOSTICS INCEquity74834L10031339275000SHSOLE27500000
GLD US 01/15/21 C150Listed Option78463V90782084000SHCallSOLE400000
GW PHARMACEUTICALS -ADRDepository Receipt36197T1031104590000SHSOLE9000000
HOLOGIC INCEquity43644010118525325000SHSOLE32500000
ICU MEDICAL INCEquity44930G1071437678000SHSOLE7800000
IVERIC BIO INCEquity46583P10251001000000SHSOLE100000000
LABORATORY CRP OF AMER HLDGSEquity50540R409913655000SHSOLE5500000
LANTHEUS HOLDINGS INCEquity51654410313585950000SHSOLE95000000
ALLSCRIPTS HEALTHCARE SOLUTIEquity01988P108108321600000SHSOLE160000000
MEDTRONIC PLCEquity58505510613755150000SHSOLE15000000
MISONIX INCEquity6048711034370322041SHSOLE32204100
MYLAN NVEquity6285301076432400000SHSOLE40000000
NATERA INCEquity632307104299260000SHSOLE6000000
NUANCE COMMUNICATIONS INCEquity67020Y10014550575000SHSOLE57500000
OPTINOSE INCEquity68404V100113461525000SHSOLE152500000
PACIRA BIOSCIENCES INCEquity69512710036729700000SHSOLE70000000
PHREESIA INCEquity71944F10611312400000SHSOLE40000000
PLEXUS CORPEquity729132100465766000SHSOLE6600000
PERRIGO CO PLCEquityG9782210326253475000SHSOLE47500000
RADNET INCEquity75049110211109700000SHSOLE70000000
RIGEL PHARMACEUTICALS INCEquity766559603125366850000SHSOLE685000000
SI-BONE INCEquity8257041091677105200SHSOLE10520000
SPY US 07/17/20 P290Listed Option78462F9538964000SHPutSOLE400000
STREAMLINE HEALTH SOLUTIONSEquity86323X10657274305882SHSOLE430588200
TEVA PHARMACEUTICAL-SP ADRDepository Receipt8816242093083250000SHSOLE25000000
TEVA US 09/18/20 C10Listed Option88162490916256500SHCallSOLE650000
UNITEDHEALTH GROUP INCEquity91324P1021032335000SHSOLE3500000
UNITED THERAPEUTICS CORPEquity91307C10221175175000SHSOLE17500000
XBI US 07/17/20 P105Listed Option78464A9502742000SHPutSOLE200000